The type 1 CD10/neutral endopeptidase 24.11 promoter: functional characterization of the 5′-untranslated region
Nobuo Sezaki
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorFumihiko Ishimaru
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorTakayuki Tabayashi
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorItaru Kataoka
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorKoichi Nakase
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorKeiko Fujii
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorTeruhiko Kozuka
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorHiroyuki Nakayama
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorMine Harada
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorMitsune Tanimoto
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorNobuo Sezaki
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorFumihiko Ishimaru
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorTakayuki Tabayashi
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorItaru Kataoka
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorKoichi Nakase
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorKeiko Fujii
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorTeruhiko Kozuka
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorHiroyuki Nakayama
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorMine Harada
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorMitsune Tanimoto
Department of Medicine, University of Okayama, Okayama, Japan
Search for more papers by this authorAbstract
Summary. The cell surface zinc metalloproteinase CD10/neutral endopeptidase 24.11 (NEP) is expressed on normal and malignant lymphoid progenitors, granulocytes and a variety of epithelial cells. Because CD10/NEP functions as part of a regulatory loop that controls local concentrations of peptide substrates and associated peptide-mediated signal transduction, its role in each tissue is different depending on the availability of substrate. To characterize further how this widely distributed molecule is regulated differentially in each tissue, we analysed the major type 2 CD10/NEP promoter and found three functionally important transcription factor binding sites, one of which was identical to CCAAT-binding transcription factor/nuclear transcription factor Y. In this report, we analyse the type 1 CD10/NEP promoter and found a functionally important transcription factor binding site in the 5′-untranslated region. The results of the competition and supershift experiments demonstrated that the functionally important transcription factor was identical to Sp1. Our results suggest that ubiquitously expressed Sp1 may play an important role in differentiation stage-specific regulation of CD10/NEP expression in lymphoid lineage.
References
- Amrolia, P.J., Cunningham, J.M., Ney, P., Nienhuis, A.W. & Jane, S.M. (1995) Identification of two novel regulatory elements within the 5′-untranslated region of the human Agamma-globin gene. Journal of Biological Chemistry, 270, 12892 – 12898.
- Black, A.R., Black, J.D. & Azizkhan-Clifford, J. (2001) Sp1 and Kruppel-like factor family of transcription factors in cell growth regulation and cancer. Journal of Cellular Physiology, 188, 143 – 160.
- Brandeis, M., Frank, D., Keshet, I., Siegfried, Z., Mendelsohn, M., Nemes, A., Temper, V., Razin, A. & Cedar, H. (1994) Sp1 elements protect a CpG island from de novo methylation. Nature, 371, 435 – 438.
- Buratowski, S. & Chodosh, L.A. (1996) Mobility shift DNA-binding assay using gel electrophoresis. In: Current Protocols in Molecular Biology (ed. by F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith & K. Struhl), pp. 12.2.1 – 12.2.11. John Wiley & Sons, New York.
- D'Adamio, L., Shipp, M.A., Masteller, E.L. & Reinherz, E.L. (1989) Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5′ untranslated regions. Proceedings of National Academy of Sciences of the USA, 86, 7103 – 7107.
- Dharmavaram, R.M., Liu, G., Mowers, S.D. & Jimenez, S.A. (1997) Detection and characterization of Sp1 binding activity in human chondrocytes and its alterations during chondrocyte dedifferentiation. Journal of Biological Chemistry, 272, 26918 – 26925.
- Dignam, J.D., Lebovitz, R.M. & Roeder, R.G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Research, 11, 1475 – 1489.
- Erdos, E.G. & Skidgel, R.A. (1989) Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB Journal, 3, 145 – 151.
- Gardiner-Garden, M. & Frommer, M. (1987) CpG islands in vertebrate genomes. Journal of Molecular Biology, 196, 261 – 282.
- Gill, G., Pascal, E., Tseng, Z.H. & Tjian, R. (1994) A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proceedings of the National Academy of Sciences of the USA, 91, 192 – 196.
- Haouas, H., Morello, D., Lavenu, A., Billard, M., Jasmin, C. & Boucheix, C. (1995) Characterization of the 5′ region of the CD10/neutral endopeptidase 24.11 gene. Biochemical and Biophysics Research Communications, 207, 933 – 942.
- Ishimaru, F. & Shipp, M.A. (1995) Analysis of the human CD10/neutral endopeptidase 24.11 promoter region: two separate regulatory elements. Blood, 85, 3199 – 3207.
- Ishimaru, F., Mari, B. & Shipp, M.A. (1997) The type 2 CD10/neutral endopeptidase 24.11 promoter: functional characterization and tissue-specific regulation by CBF/NF-Y isoforms. Blood, 89, 4136 – 4145.
- Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N.P., Gerard, C., Hama, E., Lee, H.-J. & Saido, T.C. (2001) Metabolic regulation of brain Abeta by neprilysin. Science, 292, 1550 – 1552.
- Kozak, M. (1989) Circumstances and mechanisms of inhibition of translation by secondary structure in eukaryotic mRNAs. Molecular Cellular Biology, 9, 5134 – 5142.
- Kozak, M. (1991) An analysis of vertebrate mRNA sequences: intimations of translational control. Journal of Cellular Biology, 115, 887 – 903.
- LeBien, T.W. & McCormack, R.T. (1989) The common acute lymphoblastic leukemia antigen (CD10) – emancipation from a functional enigma. Blood, 73, 625 – 635.
- LeTarte, M., Vera, S., Tran, R., Addis, J.B.L., Onizuka, R.J., Quackenbush, E.J., Jongeneel, C.V. & McInnes, R.R. (1988) Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase. Journal of Experimental Medicine, 168, 1247 – 1253.
- Li, R., Knight, J.D., Jackson, S.P., Tjian, R. & Botchan, M.R. (1991) Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription. Cell, 65, 493 – 505.
- Marin, M., Karis, A., Visser, P., Grosveld, F. & Philipsen, S. (1997) Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell, 89, 619 – 628.
- Martins, M.A., Shore, S.A., Gerald, N.P., Gerald, C. & Drazen, J.M. (1990) Peptidase modulation of the pulmonary effects of tachykinins in tracheal superfused guinea pig lungs. Journal of Clinical Investigation, 85, 170 – 176.
- Papandreou, C.N., Usmani, B., Geng, Y., Bogenrieder, T., Freeman, R., Wilk, S., Finstad, C.L., Reuter, V.E., Powell, C.T., Scheinberg, D., Magill, C., Scher, H.I., Albino, A.P. & Nanus, D.M. (1998) Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nature Medicine, 4, 50 – 57.
- Pugh, B.F. & Tjian, R. (1991) Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes and Development, 5, 1935 – 1945.
- Saffer, J.D., Jackson, S.P. & Annarella, M.B. (1991) Developmental expression of Sp1 in the mouse. Molecular Cellular Biology, 11, 2189 – 2199.
- Schibler, U. & Sierra, F. (1987) Alternative promoters in developmental gene expression. Annual Review of Genetics, 21, 237 – 257.
- Shen, R., Sumitomo, M., Dai, J., Hardy, D.O., Navarro, D., Usmani, B., Papandreou, C.N., Hersh, L.B., Shipp, M.A., Freedman, L.P. & Nanus, D.M. (2000) Identification and characterization of two androgen response regions in the human neutral endopeptidase gene. Molecular Cellular Endocrinology, 170, 131 – 142.
- Shipp, M.A. & Look, A.T. (1993) Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key! Blood, 82, 1052 – 1070.
- Shipp, M.A., Richardson, N.E., Sayre, P.H., Brown, N.R., Masteller, E.L., Clayton, L.K., Ritz, J. & Reinherz, E.L. (1988) Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type 2 integral membrane protein. Proceedings of the National Academy of Sciences of the USA, 85, 4819 – 4823.
- Shipp, M.A., Tarr, G.E., Chen, C.-Y., Switzer, S.N., Hersh, L.B., Stein, H. & Reinherz, E.L. (1991) CD10/NEP hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. Proceedings of the National Academy of Sciences of the USA, 88, 10662 – 10666.
- Spencer, C.A. & Groudine, M. (1990) Transcription elongation and eukaryotic gene regulation. Oncogene, 5, 777 – 785.
- Su, W., Jackson, S., Tjian, R. & Echols, H. (1991) DNA looping between sites for transcriptional activation: self association of DNA-bound Sp1. Genes and Development, 5, 820 – 826.
- Usmani, B.A., Shen, R., Janeczko, M., Papandreou, C.N., Lee, W.-H., Nelson, W.G., Nelson, J.B. & Nanus, D.M. (2000) Methylation of the neutral endopeptidase gene promoter in human prostate cancers. Clinical Cancer Research, 6, 1664 – 1670.
- Valhmu, W.B., Palmer, G.D., Dobson, J., Fischer, S.G. & Ratcliffe, A. (1998) Regulatory activities of the 5′- and 3′-untranslated regions and promoter of the human aggrecan gene. Journal of Biological Chemistry, 273, 6196 – 6202.
- Vinals, F., Fandos, C., Santalucia, T., Ferre, J., Testar, X., Palacin, M. & Zorzano, A. (1997) Myogenesis and MyoD down-regulate Sp1. Journal of Biological Chemistry, 272, 12913 – 12921.
- Zhang, D.-E., Hetherington, C.J., Tan, S., Dziennis, S.E., Gonzalez, D.A., Chen, H.-M. & Tenen, D.G. (1994) Sp1 is a critical factor for the monocytic specific expression of human CD14. Journal of Biological Chemistry, 269, 11425 – 11434.